Abbott Wants To Expand Clinical Trial Access By Diversifying Investigator Community
Executive Summary
The company’s plan to reduce barriers to clinical trial participation for underrepresented groups includes the creation of nearly 300 new scholarships at medical schools of historically black colleges and universities and minority nursing associations.
You may also be interested in...
Decentralized Trials Are Here To Stay; What Challenges Do They Face?
Decentralized trials took a leap in popularity over the past few years, in part thanks to the COVID-19 pandemic. In Vivo's sister publication Medtech Insight spoke to two executives at clinical research technology companies about running decentralized clinical trials to discuss the benefits and limitations of trials run remotely.
Decentralized Trials Are Here To Stay; What Challenges Do They Face?
Decentralized trials took a leap in popularity over the past few years, in part thanks to the COVID-19 pandemic. Medtech Insight spoke to two executives at clinical research technology companies about running decentralized clinical trials to discuss the benefits and limitations of trials run remotely.
How We Can Use the FDA’s 2022 Diversity Guidance to Make Our Clinical Trials More Inclusive
Catherine Gregor is the chief clinical trial officer at Florence Healthcare, a leading provider of clinical trial software that helps researchers collaborate and manage workflows and information. Based on her extensive experience in clinical research administration, Gregor explains how the recent US FDA guidance on diversity and inclusion in clinical trials represents a critical opportunity to make clinical research more inclusive and equitable.